You can now add your name to our electronic mailing list
| Online edition Table of Contents Editorial Board Instructions to authors Back Volumes Mailing dates Contacts | Inflammopharmacology Editor-in-Chief: Section Editors: Rheumatology -- N. Bellamy, University of Queensland, Departmentof Medicine, Royal Brisbane Hospital, Brisbane, Queensland 4029,Australia Gastroenterology -- Gy. Mózsik, 1 Conditional Pharmacology -- M.C. Powanda, M/P BiomedicalConsultants, 435 Marin Avenue, Mill Valley, CA, 94941, USA; andM.W. Whitehouse, Department of Medicine,University of Queensland,Brisbane, Queensland 4072, Australia Neuroinflammation -- J. Walker, School of Physiology andPharmacology, University of New South Wales, Kensington, NSW,Australia New Drug Development -- S. Laufer, Pharmazeutisches Institut,Universität Tübingen, Auf der Morgenstelle 8, D-72076,Tübingen, Germany Editorial Consultants:
Inflammopharmacology accepts contributions on experimental andclinical studies in the interdisciplinary field of inflammation andits pharmacological control. Of particular interest are: wherecomparisons of drug response in one inflammatory disease arecontrasted with those in others; where comparisons of different drugsare made within a disease entity; and where varying pathologyinfluences drug response. Clinical and experimental studies on newdrugs in development are welcome, as are those on drugs which havebeen withdrawn from clinical use where publication of the informationwould be useful. ISSN 0925-4692 Indexed/Abstracted in: Subscription data 2005 (all prices are subject to change without notice):
|
VSPPostal address: P.O. Box 9000, 2300 PA Leiden, The Netherlands